Using genomic analysis to build the future of cell-specific cancer therapies to reach a broader range of patients

Universal platform for the life sciences, redefining the boundaries of scientific discovery with  super-resolution microscopy 

Novel AAV gene therapy platform for safe durable expression of cytokine immunotherapies, agnostic to tumor antigen, mutation and cancer type 

Helping clinicians provide superior cardiopulmonary disease screening and detection, surpassing over 130K devices in the market globally

Building the most patient-friendly marketplace for clinical trials that is easy to understand, allowing patients to find life-changing medicine

An estimated $10M+ saved in temporary disability payments by providing access to care nearly 6 days sooner on average

Working with the National Institute on Drug Abuse (NIDA) on preclinical animal studies to test Delix’s ibogaine analogue as a potential treatment for a range of substance-use disorders

Heading into human testing with their potential functional cure for chronic HIV

Revolutionizing the field of proteomics through their next-generation protein sequencing platform to gain novel insights into biology and disease

Provided access to affordable, convenient mental health care to 200K+ individuals

Completed first in-human clinical trial to demonstrate the impact of their robotics platform in helping prevent costly and 
life-threatening complications from surgeries

Helping the 70%+ of people with dietary restrictions find food that works with their diet and enjoy eating again

Completed first-of-its-kind trial for a new class of precision engineered bacteriophage treatments to target infectious disease and combat antibiotic resistance